Smith & Nephew SNATS Inc (NYSE:SNN)
26.08 USD
-0.340 1.287%Previous Close (in USD) | 26.42 |
---|---|
Change | -0.340 1.287% |
52 W H/L (in USD) | 32.684/21.530 |
EBITDA (in USD) | 1135M |
PE Ratio | 54.74 |
Volume | 724250 |
Diluted Eps TTM | 0.50 |
Total Assets (in USD) | 9966M |
---|---|
Total Liabilities (in USD) | 4707M |
Revenue TTM (in USD) | 5349M |
Cash (in USD) | 350M |
Market Cap (in USD) | 11,952.453 M |
Revenue Per Share TTM | 2.458 |
Gross Profit TTM (in USD) | 3695M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Smith & Nephew SNATS Inc
Employees: 19000
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Ms. Anne-Francoise Nesmes | CFO & Exec. Director | 1972 |
2. | Dr. Deepak S. Nath Ph.D. | CEO & Director | 1973 |
3. | Mr. Paul Connolly | Pres of Global Operations | 1968 |
4. | Mr. Andrew Swift | VP of Investor Relations | NA |
5. | Ms. Helen Barraclough | Group Gen. Counsel, Company Sec. & Director | 1979 |
6. | Ms. Alison Parkes | Chief Compliance Officer | 1972 |
7. | Mr. Joe Metzger | Sr. VP of Marketing Services & Communications | NA |
8. | Ms. Elga Lohler | Chief HR Officer | 1968 |
9. | Mr. Philip G. Cowdy | Chief Bus. Devel. & Corp. Affairs Officer | 1967 |
10. | Mr. Bradley Cannon | Pres of Orthopaedics, Sports Medicine & ENT and Americas | 1968 |
Peers
Sector: Healthcare
Industry: Medical Devices
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
ABT
Abbott Laboratories |
+0.010 0.009% | 111.95 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
SYK
Stryker Corporation |
+0.320 0.091% | 353.96 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
MDT
Medtronic PLC |
+0.060 0.072% | 83.57 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
BSX
Boston Scientific Corp |
+0.120 0.178% | 67.43 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | 235M | 586M | 246M | 743M | 781M |
Minority Interest | - | - | - | - | - |
Net Income | 223M | 524M | 448M | 600M | 663M |
Selling General Administrative | 2880M | 2720M | 2562M | 2693M | 2497M |
Gross Profit | 3675M | 3669M | 3164M | 3800M | 3606M |
Reconciled Depreciation | 628M | 581M | 562M | 502M | 435M |
Ebit | 315M | 591M | 308M | 808M | 840M |
Ebitda | 943M | 1172M | 904M | 1326M | 1294M |
Depreciation And Amortization | 628M | 581M | 596M | 518M | 454M |
Operating Income | 450M | 593M | 295M | 815M | 863M |
Other Operating Expenses | 4765M | 4619M | 4265M | 4323M | 4041M |
Interest Expense | 80M | 80M | 62M | 65M | 59M |
Tax Provision | 12M | 62M | -202M | 143M | 118M |
Interest Income | 14M | 6M | 6M | 43M | 52M |
Net Interest Income | -74M | -91M | -63M | -73M | -71M |
Income Tax Expense | 12M | 62M | -202M | 143M | 118M |
Total Revenue | 5215M | 5212M | 4560M | 5138M | 4904M |
Total Operating Expenses | 3225M | 3076M | 2869M | 2985M | 2743M |
Cost Of Revenue | 1540M | 1543M | 1396M | 1338M | 1298M |
Total Other Income Expense Net | -430M | -126M | -187M | -238M | -195M |
Net Income From Continuing Ops | 223M | 524M | 448M | 600M | 663M |
Net Income Applicable To Common Shares | 223M | 524M | 448M | 600M | 663M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Total Assets | 9966M | 10920M | 11012M | 9299M | 8059M |
Intangible Assets | 1236M | 1398M | 1486M | 1567M | 1210M |
Other Current Assets | 9027M | 1290M | 1211M | 1328M | 1317M |
Total Liab | 4707M | 5352M | 5733M | 4158M | 3185M |
Total Stockholder Equity | 5259M | 5568M | 5279M | 5141M | 4874M |
Other Current Liab | 686M | 1088M | 797M | 623M | 611M |
Common Stock | 175M | 177M | 177M | 177M | 177M |
Capital Stock | 175M | 177M | 177M | 177M | 177M |
Retained Earnings | 5026M | 5225M | 4958M | 4849M | 4625M |
Good Will | 3031M | 2989M | 2928M | 2789M | 2337M |
Other Assets | 330M | 398M | 368M | 291M | 234M |
Cash | 350M | 1290M | 1762M | 277M | 365M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 1715M | 2131M | 1688M | 1564M | 1465M |
Current Deferred Revenue | -229M | -544M | -468M | -177M | -267M |
Net Debt | 2522M | 2049M | 1928M | 1770M | 1100M |
Short Term Debt | 160M | 491M | 337M | 72M | 164M |
Short Long Term Debt | 111M | 435M | 279M | 26M | 164M |
Short Long Term Debt Total | 2872M | 3339M | 3690M | 2047M | 1465M |
Other Stockholder Equity | -5201M | -5402M | -5135M | -5026M | -4802M |
Property Plant Equipment | 1455M | 1513M | 1449M | 1323M | 1062M |
Total Current Assets | 3856M | 4424M | 4664M | 3219M | 3077M |
Long Term Investments | - | - | - | 110M | 139M |
Short Term Investments | - | -182M | -133M | -106M | - |
Net Receivables | -7726M | 1290M | 1106M | 1227M | 1211M |
Long Term Debt | 2565M | 2707M | 3207M | 1835M | 1301M |
Inventory | 2205M | 1844M | 1691M | 1614M | 1395M |
Accounts Payable | 1098M | 1096M | 1022M | 1046M | 957M |
Accumulated Other Comprehensive Income | - | - | -311M | -2034M | -1821M |
Non Currrent Assets Other | 153M | 197M | 166M | 141M | 108M |
Non Current Assets Total | 6110M | 6496M | 6348M | 6080M | 4982M |
Capital Lease Obligations | 196M | 197M | 204M | 170M | - |
Long Term Debt Total | 2712M | 2848M | 3353M | 1975M | 1301M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -472M | 2M | -606M | -1251M | -378M |
Total Cashflows From Investing Activities | -472M | -691M | -606M | -1251M | -378M |
Total Cash From Financing Activities | -926M | -645M | 1164M | 7M | -371M |
Net Income | 235M | 586M | 246M | 743M | 781M |
Change In Cash | -941M | -466M | 1494M | -76M | 178M |
Begin Period Cash Flow | 1285M | 1751M | 257M | 333M | 155M |
End Period Cash Flow | 344M | 1285M | 1751M | 257M | 333M |
Total Cash From Operating Activities | 468M | 877M | 935M | 1168M | 931M |
Depreciation | 628M | 581M | 596M | 518M | 454M |
Other Cashflows From Investing Activities | -114M | -283M | -163M | -843M | -31M |
Dividends Paid | -327M | -329M | -328M | -318M | 321M |
Change To Inventory | -407M | -151M | -45M | -204M | -152M |
Sale Purchase Of Stock | -158M | -59M | -16M | -63M | -48M |
Other Cashflows From Financing Activities | 434M | -4M | 1902M | 1242M | -8M |
Capital Expenditures | 358M | 408M | 443M | 408M | 347M |
Change In Working Capital | -535M | -150M | 61M | 27M | -189M |
Other Non Cash Items | 66M | 74M | 56M | 55M | -375M |
Free Cash Flow | 110M | 469M | 492M | 760M | 584M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Nuance Mid Cap Value Separate Account | 5 months ago | 4839410 |
2. | Nuance Mid Cap Value Institutional | 7 months ago | 3605324 |
3. | American Century U.S. Mid Cap Value | 5 months ago | 1627432 |
4. | American Century Mid Cap Value Inv | 5 months ago | 1627432 |
5. | FMI Large Cap Investor | 5 months ago | 1435000 |
6. | Scharf Quality Value | 4 months ago | 1117218 |
7. | Nuance Concentrated Value | 5 months ago | 700468 |
8. | Nuance Concentrated Value Institutional | 7 months ago | 428841 |
9. | Arrowstreet IntlEqWldxUS Alpha Ext CIT D | 8 months ago | 387637 |
10. | JNL Multi-Manager Mid Cap A | 5 months ago | 372896 |
11. | MDPIM US Equity Pool | 5 months ago | 356943 |
12. | 1290 VT Equity Income IB | 4 months ago | 329341 |
13. | Fiduciary Mgt of Milwaukee Lg-Cap Eq | 5 months ago | 284530 |
14. | Liberty All-Star Equity | 5 months ago | 278538 |
15. | Barrow Hanley Dividend Focused Value Eq | 5 months ago | 278518 |
16. | 1832 AM U.S. Low Volatility Equity LP I | 4 months ago | 273155 |
17. | Nuance Concentrated Value L-S Invt | 7 months ago | 249186 |
18. | American Century US Mid Cap Val Eq Tr 1 | 5 months ago | 195279 |
19. | Scharf Multi-Asset Composite | 4 months ago | 186827 |
20. | abrdn World Healthcare | 4 months ago | 181710 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Mariner Value Strategies, LLC | 5 months ago | 7158581 |
2. | Fiduciary Management, Inc. of Milwaukee | 5 months ago | 5246093 |
3. | Scharf Investments | 5 months ago | 2473860 |
4. | American Century Companies Inc | 5 months ago | 2364037 |
5. | Bank of America Corp | 8 months ago | 1742727 |
6. | Morgan Stanley - Brokerage Accounts | 8 months ago | 1653881 |
7. | Barrow Hanley Mewhinney & Strauss LLC | 5 months ago | 1338996 |
8. | Arrowstreet Capital Limited Partnership | 5 months ago | 1240852 |
9. | Goldman Sachs Group Inc | 8 months ago | 1217822 |
10. | BlackRock Inc | 8 months ago | 1005408 |
11. | Millennium Management LLC | 8 months ago | 798190 |
12. | Wells Fargo & Co | 8 months ago | 755457 |
13. | FMR Inc | 8 months ago | 737025 |
14. | Soleus Capital Management, L.P. | 5 months ago | 653900 |
15. | JPMorgan Chase & Co | 8 months ago | 616410 |
16. | Raymond James & Associates | 8 months ago | 603291 |
17. | Bank of Montreal | 8 months ago | 554680 |
18. | BMO Capital Markets Corp. | 8 months ago | 554680 |
19. | Clark Estates Inc | 5 months ago | 550000 |
20. | Qube Research & Technologies | 8 months ago | 414137 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).